4//SEC Filing
Frazier Life Sciences IX, L.P. 4
Accession 0001209191-19-043024
CIK 0001759425other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 4:17 PM ET
Size
14.3 KB
Accession
0001209191-19-043024
Insider Transaction Report
Form 4
Frazier Life Sciences IX, L.P.
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2019-07-22−24,935,300→ 0 total→ Common Stock (3,116,912 underlying) - Purchase
Common Stock
2019-07-22$15.00/sh+450,000$6,750,000→ 3,566,912 total - Conversion
Common Stock
2019-07-22+3,116,912→ 3,116,912 total
Topper James N
10% Owner
Transactions
- Conversion
Common Stock
2019-07-22+3,116,912→ 3,116,912 total - Conversion
Series A Preferred Stock
2019-07-22−24,935,300→ 0 total→ Common Stock (3,116,912 underlying) - Purchase
Common Stock
2019-07-22$15.00/sh+450,000$6,750,000→ 3,566,912 total
FHMLS IX, L.P.
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2019-07-22−24,935,300→ 0 total→ Common Stock (3,116,912 underlying) - Conversion
Common Stock
2019-07-22+3,116,912→ 3,116,912 total - Purchase
Common Stock
2019-07-22$15.00/sh+450,000$6,750,000→ 3,566,912 total
FHMLS IX, L.L.C.
10% Owner
Transactions
- Conversion
Common Stock
2019-07-22+3,116,912→ 3,116,912 total - Purchase
Common Stock
2019-07-22$15.00/sh+450,000$6,750,000→ 3,566,912 total - Conversion
Series A Preferred Stock
2019-07-22−24,935,300→ 0 total→ Common Stock (3,116,912 underlying)
Footnotes (3)
- [F1]In connection with the Issuer's initial public offering, each share of the Issuer's Series A Preferred Stock automatically converted into 0.125 shares of the Issuer's Common Stock. The shares have no expiration date.
- [F2]The shares are held directly by Frazier Life Sciences IX, L.P. FHMLS IX, L.P. is the general partner of Frazier Life Sciences IX, L.P. FHMLS IX, L.L.C. is the general partner of FHMLS IX, L.P. James N. Topper and Patrick Heron are the managing members of FHMLS IX, L.L.C. and share voting and dispositive power over the shares held by Frazier Life Sciences IX, L.P. Mr. Topper, FHMLS IX, L.P. and FHMLS IX, L.L.C. disclaim beneficial ownership of the shares held by Frazier Life Sciences IX, L.P., except to the extent of his or its pecuniary interest therein, if any.
- [F3]The shares were purchased in the Issuer's initial public offering.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001720320
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 4:17 PM ET
- Size
- 14.3 KB